INDEGENE
Back to Balance Sheet
|
INDEGENE Last 5 Year Total Liabilities History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Total Liabilities | ₹3,236 Cr | ₹2,475 Cr | ₹2,137 Cr | ₹1,284 Cr | ₹559 Cr |
What is the latest Total Liabilities ratio of INDEGENE ?
Year | Total Liabilities |
---|---|
Mar2025 | ₹3,236 Cr |
Mar2024 | ₹2,475 Cr |
Mar2023 | ₹2,137 Cr |
Mar2022 | ₹1,284 Cr |
Mar2021 | ₹559 Cr |
How is Total Liabilities of INDEGENE Trending?
Years | Total Liabilities | % Change | |
---|---|---|---|
Mar2025 | ₹3,236 Cr | 30.76 | |
Mar2024 | ₹2,475 Cr | 15.82 | |
Mar2023 | ₹2,137 Cr | 66.38 | |
Mar2022 | ₹1,284 Cr | 129.63 | |
Mar2021 | ₹559 Cr | - |
Compare Total Liabilities of peers of INDEGENE
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
INDEGENE | ₹13,490.0 Cr | 2.8% | -1.3% | -7.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,622.0 Cr | 2% | -2.3% | -12.6% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,536.0 Cr | -1.3% | -6.2% | 21.2% | Stock Analytics | |
CIPLA | ₹125,468.0 Cr | -2.2% | 3.6% | -4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,162.0 Cr | -0% | -0.3% | 5% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,874.0 Cr | -0.9% | 4.5% | -8.6% | Stock Analytics |
INDEGENE Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
INDEGENE | 2.8% |
-1.3% |
-7.3% |
SENSEX | 1.1% |
-0.4% |
-2.2% |
You may also like the below Video Courses